PHARMACEUTICAL COMPOSITION CONTAINING PROTEIN KINASE C ACTIVATOR-TREATED STEM CELLS OR CULTURE THEREOF FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES

Title:

PHARMACEUTICAL COMPOSITION CONTAINING PROTEIN KINASE C ACTIVATOR-TREATED STEM CELLS OR CULTURE THEREOF FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES

Document Type and Number:

WIPO Patent Application WO/2020/096340

Kind Code:

A1

Abstract:

The present invention relates to a pharmaceutical composition containing protein kinase C activator-treated stem cells or a culture thereof for preventing or treating autoimmune diseases, more specifically to a pharmaceutical composition which can inhibit B-cell function to thus be superbly effective in preventing or treating autoimmune diseases.

More Like This:

WO/2009/114826	TREATMENT SYSTEMS AND METHODS FOR RENAL-RELATED DISEASES
JP2022513378	Nervous system cell therapy
JP2013116854	METHOD FOR PRODUCING ERYTHROPOIETIN, AND METHOD FOR ISOLATING ERYTHROPOIETIN-PRODUCING CELLS

Inventors:

KIM KYUNG SUK (KR)
LEE TAE YONG (KR)

Application Number:

PCT/KR2019/014960

Publication Date:

May 14, 2020

Filing Date:

November 06, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CORESTEM CO LTD (KR)

International Classes:

A61K35/28; A61K31/215; A61K35/545; A61P37/06; C12N5/0775

Foreign References:

KR20160109356A

2016-09-21

Other References:

MIZUGUCHI, J. ET AL.: "Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cells", PNAS, June 1986 (1986-06-01), pages 4474 - 4478, XP055704948
CAS , no. 102649-79-6
See also references of EP 3878458A4

Attorney, Agent or Firm:

ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: BIOMARKER FOR PREDICTING ABILITY OF MESENCHYMAL STEM CELLS TO PROLIFERATE AND MIGRATE

Next Patent: DISPLAY DEVICE AND METHOD FOR CONTROLLING SAME